Clik here to view.
Fractional Flow Reserve: Measuring Pressures in the Marketplace
Dr. Andreas Gruentzig “I don’t know how anyone can do these procedures without measuring pressures!” That’s what Andreas Gruentzig, the father of coronary angioplasty, said to me back in 1985. He knew...
View ArticleClik here to view.
Plavix and Aspirin After Stent: 8 Years Later – Is Longer Better?
No one thought it would take quite so long to get this information, but in just a couple hours results from the Dual Antiplatelet Therapy (DAPT) Study will be presented at the American Heart...
View ArticleClik here to view.
From Bench to Bedside to Bench Revisited: Supreme Court Justice Ginsburg Back...
Almost two decades ago, interventional cardiology pioneer Dr. Spencer B. King III penned an article for Circulation titled, “Angioplasty From Bench to Bedside to Bench.” Dr. King’s article was a...
View ArticleClik here to view.
iFR and iFR Scout to be Featured in Live Case from Hammersmith
Dr. Justin Davies discusses value of using physiology-guided PCI If you’ve been wondering what iFR (Instant wave-Free Ratio) is, how it works, how it compares to FFR (Fractional Flow Reserve) and, most...
View ArticleClik here to view.
COURAGE: Does 15-Year Data Have Any Clinical Relevance?
This past week saw publication of an update to the 2007 COURAGE trial which compared optimal medical therapy (OMT) to stenting (PCI) as the initial management strategy for stable coronary artery...
View ArticleClik here to view.
NORSTENT: Drug-Eluting Stents – Doing What They’re Supposed To
At this week’s annual European Society of Cardiology Congress in Rome, an important randomized clinical trial on stents was presented by Professor Kaare H. Bønaa, MD, PhD of the Clinic for Heart...
View ArticleClik here to view.
Interventional Cardiology Late-Breakers at ACC.17
Washington Convention Center Over the next three days, a voluminous amount of data will be presented, shared, and debated among an estimated 18,000 attendees of the annual meeting of the American...
View ArticleClik here to view.
Status of the “Disappearing Stent” in Europe: It’s Complicated!
Last night news began circulating on Twitter that Abbott’s Absorb BVS (Bioresorbable Vascular Scaffold) was being withdrawn from the European market. This information was prompted by several physicians...
View ArticleClik here to view.
History, Gruentzig, and Abbott’s Absorb “Dissolving Stent”
Abbott’s Absorb “Dissolving Stent” There’s a lesson for the Absorb BVS in the history of interventional cardiology (an area of particular interest in this 40th anniversary of angioplasty year). There’s...
View ArticleClik here to view.
Post-Dilatation Stent Sizes
click for hi-res PDF of chart For the interventionalist, proper sizing of coronary stents is critical. While imaging via angiography has been the standard for years, newer intravascular imaging...
View Article
